Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trialRalf‐Dieter Hofheinz, Andreas Hochhaus, Lothar Müller et al.|The Lancet Oncology|2012Cited by 505
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trialAlexander Stein, Dirk Arnold, Albrecht Kretzschmar et al.|BMC Cancer|2013Cited by 0
Capecitabine (C) and bevacizumab (B) for nonresectable metastatic colorectal cancer (mCRC) patients: Results from phase II AIO 0105 trial.Albrecht Kretzschmar, Dirk Arnold, D. Behringer et al.|Journal of Clinical Oncology|2010Cited by 0